Skip to Content

Lidocaine with Epinephrine Injection

Last Updated: December 29, 2017
Status: Resolved

Lidocaine with Epinephrine Injection

Products Affected - Description
  • Lidocaine (with epinephrine 1:100,000) injection, Pfizer

1%, 20 mL vial, 100 count (NDC 00409-3178-01)
1%, 30 mL vial, 100 count (NDC 00409-3178-02)
1%, 50 mL vial, 100 count (NDC 00409-3178-03)
2%, 20 mL vial, 100 count (NDC 00409-3182-01)
2%, 30 mL vial, 100 count (NDC 00409-3182-02)
2%, 50 mL vial, 100 count (NDC 00409-3182-03)
 
Lidocaine (with epinephrine 1:200,000) injection, Pfizer
0.5%, 50 mL vial, 100 count (NDC 00409-3177-01)
1.5%, 5 mL glass ampule, 10 count (NDC 00409-1209-01)
1.5%, 30 mL vial, 25 count (NDC 00409-3181-01)
2%, 20 mL vial, 25 count (NDC 00409-3183-01)
 
Xylocaine (with epinephrine 1:200,000) injection, Fresenius Kabi
0.5%, 50 mL vial, 25 count (NDC 63323-0481-57)
1%, 10 mL vial, 25 count (NDC 63323-0482-17)
1%, 20 mL vial, 25 count (NDC 63323-0482-27)
1%, 50 mL vial, 25 count (NDC 63323-0482-57)
2%, 20 mL vial, 25 count (NDC 63323-0483-27)
2%, 50 mL vial, 25 count (NDC 63323-0483-57)
 
Xylocaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi
1%, 10 mL vial, 25 count (NDC 63323-0487-17)
1%, 30 mL vial, sterile-pack 5 count (NDC 63323-0487-31)
1%, 30 mL vial, 25 count (NDC 63323-0487-37)
1.5%, 10 mL vial, 25 count (NDC 63323-0488-17)
1.5%, 30 mL vial, sterile-pack 5 count (NDC 63323-0488-31)
1.5%, 30 mL vial, 25 count (NDC 63323-0488-37)
2%, 10 mL vial, 25 count (NDC 63323-0489-17)
2%, 20 mL vial, sterile-pack 5 count (NDC 63323-0489-21)
2%, 20 mL vial, 25 count (NDC 63323-0489-27)
Reason for the Shortage
    • Fresenius Kabi has Xylocaine with epinephrine presentations on shortage due to increased demand for the product and manufacturing delays.
    • Pfizer has lidocaine with epinephrine presentations on shortage due to manufacturing delays.
Available Products
  • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Pfizer has 0.5% lidocaine with epinephrine (1:200,000) 50 mL on back order and the company estimates a release date of 2nd quarter 2018. The 1% lidocaine with epinephrine (1:100,000) 20 mL vials are on back order and the company estimates a release date of late-February 2018.The 1% lidocaine with epinephrine (1:100,000) 50 mL vials are on intermittent back order and the company is releasing product as it becomes available. The 1% lidocaine with epinephrine (1:100,000) 30 mL vials are on intermittent back order and the company is releasing product as it becomes available. The 1.5% lidocaine with epinephrine (1:200,000) 30 mL vials are on back order and the company estimates a release date of 1st quarter 2018. The 1.5% lidocaine with epinephrine (1:200,000) 5 mL ampules are available in limited supply. The 2% lidocaine with epinephrine (1:200,000) 20 mL vials are on back order and the company estimates a release date of 2nd quarter 2018. The 2% lidocaine with epinephrine (1:100,000) 20 mL, 30 mL, and 50 mL vials are on back order and the company estimates a release date of 2nd quarter 2018 for the 20 mL and 30 mL vials and 1st quarter 2018 for the 50 mL vials.
    • Fresenius Kabi has 0.5% Xylocaine with epinephrine (1:200,000) 50 mL vials on back order and the company estimates a release date of mid-February 2018. The 1% Xylocaine with epinephrine (1:200,000) 20 mL and 50 mL vials are on intermittent back order and the company is releasing product as it becomes available. The 1% Xylocaine-MPF with epinephrine (1:200,000) 30 mL vials are on back order and the company estimates a release date of early- to mid-January 2018. The 1% Xylocaine with epinephrine (1:200,000) 10 mL vials and 1% Xylocaine-MPF with epinephrine (1:200,000) 10 mL vials are on back order and the company cannot estimate a release date. The 1% Xylocaine-MPF with epinephrine (1:200,000) 30 mL vials in sterile packs are on back order and the company cannot estimate a release date. The 1.5% Xylocaine-MPF with epinephrine (1:200,000) 10 mL and 30 mL vials are on back order and the company cannot estimate a release date. The 1.5% Xylocaine-MPF with epinephrine (1:200,000) 30 mL vials in sterile packs are on back order and the company cannot estimate a release date. The 2% Xylocaine with epinephrine (1:200,000) 20 mL vials are on intermittent back order and the company is releasing product as it becomes available. The 2% Xylocaine with epinephrine (1:200,000) 50 mL vials are on back order and the company cannot estimate a release date. The 2% Xylocaine-MPF with epinephrine (1:200,000) 10 mL vials are on back order and the company cannot estimate a release date. The 2% Xylocaine-MPF with epinephrine (1:200,000) 20 mL vials are on intermittent back order and the company is releasing product as it becomes available. The 2% Xylocaine-MPF with epinephrine (1:200,000) 20 mL vials in sterile packs are on back order and the company cannot estimate a release date.

Updated

December 29, 11 and 6, November 22 and 2, September 30 and 8, August 25 and 17, July 31 and 7, June 22, 12 and 6, May 15 and 11, April 30, 13 and 3, March 21, 12 and 1, February 21 and 14, January 27, 13 and 5, 2017; December 20, 9 and 2, November 11 and 4, May 26, 2016; August 6, July 17, June 25, May 11, April 15, March 27, February 20 and 3, January 23 and 7, 2015; December 12, November 9, October 25 and 17, August 22 and 9, June 21, May 30, April 16, March 7, February 22 and 8, January 25 and 3, 2012; December 16, 2011, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide